Scientists Identify Source of Weight Gain From Antipsychotics

DALLAS – May 12, 2021 – Scientists with UT Southwestern’s Peter O’Donnell Jr. Brain Institute have identified the molecular mechanism that can cause weight gain for those using a common antipsychotic medication. The findings, published in the Journal of Experimental Medicine, suggest new ways to counteract the weight gain, including a drug recently approved to treat genetic obesity, according to the study, which involved collaborations with scientists at UT Dallas and the Korea Advanced Institute of Science and Technology.

Mount Sinai Researchers Develop a First-in-Class Humanized Antibody Targeting Bone and Fat

Blocking the Follicle-Stimulating Hormone (FSH) whose levels rise at menopause could solve bone loss and weight gain Senior Author: Mone Zaidi, MD, PhD, MACP, Director of the Mount Sinai Bone Program and Professor of Medicine (Endocrinology, Diabetes and Bone Disease) at…

How the Global Pandemic is Impacting Patients with Eating Disorders

From isolation to weight gain to the anxiety of remote learning, the global pandemic presents a variety of reasons why those with eating disorders are having a difficult time managing their health conditions. Jessie Menzel, MD, pediatric program manager with…

Mount Sinai Researcher’s Examine the Metabolic Effects of an Oral Blood Cancer Drug

Recent study found that an effective blood cancer treatment was associated with weight gain, obesity, and increased systolic blood pressure